Phenomic AI
Phenomic AI is a biotech company focused on developing therapies for solid tumors using its advanced machine learning-powered transcriptomics platform. The company aims to improve outcomes for patients with challenging cancers by understanding tumor biology through single-cell RNA data analysis. Their lead program is a CD3 engager targeting tumor-associated antigens, which is currently in the development candidate stage. Phenomic differentiates itself by leveraging AI to identify novel druggable targets and testing drugs in human tumor explants, positioning itself as a pioneer in the field of cancer therapeutics. With strategic collaborations and a strong scientific advisory board, Phenomic is poised to make significant advancements in cancer treatment.
Phenomic AI
Phenomic AI is a biotech company focused on developing therapies for solid tumors using its advanced machine learning-powered transcriptomics platform. The company aims to improve outcomes for patients with challenging cancers by understanding tumor biology through single-cell RNA data analysis. Their lead program is a CD3 engager targeting tumor-associated antigens, which is currently in the development candidate stage. Phenomic differentiates itself by leveraging AI to identify novel druggable targets and testing drugs in human tumor explants, positioning itself as a pioneer in the field of cancer therapeutics. With strategic collaborations and a strong scientific advisory board, Phenomic is poised to make significant advancements in cancer treatment.